Yusuke Nakamura to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications Yusuke Nakamura has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.233
-
FZD10-targeted a-radioimmunotherapy with 225 Ac-labeled OTSA101 achieves complete remission in a synovial sarcoma model. Cancer Sci. 2022 Feb; 113(2):721-732.
Score: 0.140
-
Importance of immunopharmacogenomics in cancer treatment: Patient selection and monitoring for immune checkpoint antibodies. Cancer Sci. 2016 Feb; 107(2):107-15.
Score: 0.093